Breaking News Instant updates and real-time market news.

MGM

MGM Resorts

$34.88

0.41 (1.19%)

, GSK

GlaxoSmithKline

$35.99

0.5 (1.41%)

07:30
02/07/18
02/07
07:30
02/07/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Tuesday in MGM Resorts (MGM), GlaxoSmithKline (GSK), Huntington Bancshares (HBAN), Match Group (MTCH), and Etsy (ETSY).

MGM

MGM Resorts

$34.88

0.41 (1.19%)

GSK

GlaxoSmithKline

$35.99

0.5 (1.41%)

HBAN

Huntington Bancshares

$15.53

0.1 (0.65%)

MTCH

Match Group

$33.26

-0.57 (-1.68%)

ETSY

Etsy

$18.71

0.27 (1.46%)

  • 07

    Feb

  • 07

    Feb

  • 07

    Feb

  • 20

    Feb

  • 06

    Mar

  • 20

    Mar

  • 25

    Mar

  • 23

    Apr

MGM MGM Resorts
$34.88

0.41 (1.19%)

01/16/18
MSCO
01/16/18
NO CHANGE
MSCO
Morgan Stanley raises 2018 Macau gaming revenue growth forecast to 16%
Morgan Stanley analyst Thomas Allen raised his 2018 Macau gaming revenue growth forecast to 16% from 11%, noting that Q4 revenue growth of 20% topped his expectation for growth of 15% and he sees an opportunity for "lower tier" Chinese cities to support faster growth. Among casino names, Allen names Wynn Resorts (WYNN) as his top pick in U.S. Gaming and Lodging, calling MGM Resorts (MGM) his next favorite stock in the space. Other publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS) and Melco Resorts (MLCO).
01/09/18
JPMS
01/09/18
NO CHANGE
Target $44
JPMS
Overweight
JPMorgan calls MGM 'best absolute value' in gaming for 2018
MGM Resorts offers the gaming sector's most attractive risk/reward for 2018, JPMorgan analyst Joseph Greff tells investors in a research note. Following stock rallies in the sector last year, MGM is now the "best absolute value play," the analyst adds. He views expectations as reasonable and upped his price target for the stock to $44 from $41. Greff keeps an Overweight rating on MGM Resorts.
01/04/18
DBAB
01/04/18
NO CHANGE
Target $183
DBAB
Buy
Deutsches says Wynn Resorts 'the one to buy' in Gaming
Deutsche Bank analyst Carlo Santarelli raised his price target for Wynn Resorts (WYNN) to $183 from $170 and says the stock is the "one to buy" in Gaming. The analyst believes "late cycle dynamics could become clearer" in 2018 regarding Las Vegas trends and he prefers to play the "hot hand." He thinks Wynn can outperform and keeps a Buy rating on the shares. Santarelli also raised his price target for Hold-rated MGM Resorts (MGM) to $38 from $37 and for Hold-rated Las Vegas Sands (LVS) to $65 from $63.
01/18/18
JEFF
01/18/18
INITIATION
Target $43
JEFF
Buy
MGM Resorts initiated with a Buy at Jefferies
Jefferies analyst David Katz started MGM Resorts (MGM) with a Buy rating and $43 price target. The analyst says the Cotai opening in the near term and positive capital deployment trump concerns over challenging Las Vegas comparisons. Katz initiated 11 Gaming names after today's close, naming Wynn Resorts (WYNN), Eldorado Resorts (ERI) and Penn National (PENN) his top picks.
GSK GlaxoSmithKline
$35.99

0.5 (1.41%)

01/22/18
WELS
01/22/18
NO CHANGE
WELS
Underperform
Teva can't afford more pipeline setbacks, says Wells Fargo
After Teva (TEVA) reported that its Phase 3 registration study evaluating subcutaneously administered reslizumab in a pre-filled syringe did not meet its primary endpoint, Wells Fargo analyst David Maris said he believes this puts Teva at a disadvantage versus peers AstraZeneca (AZN) and GlaxoSmithKline (GSK) at a time when Teva cannot afford more pipeline setbacks. Subcutaneous reslizumab was not a major focus, but the news is still "another disappointment," said Maris, who keeps an Underperform rating on Teva shares.
01/22/18
WBLR
01/22/18
NO CHANGE
WBLR
Outperform
Dynavax has sold off 30% since Heplisav approval, says William Blair
Dynavax (DVAX) shares have pulled back about 30% since the U.S. approval of Heplisav, the first and only two-dose hepatitis B vaccine that has demonstrated "superiority in efficacy and comparability" in safety to the standard of care, GlaxoSmithKline's (GSK) Engerix-B, William Blair analyst Katherine Xu tells investors in a research note. The analyst attributes the selloff to Dynavax electing to launch Heplisav on its own and the Street having insufficient confidence in the launch. She believes Heplisav has peak U.S. sales prospects of $600M and "provides a valuation floor." Xu also sees catalysts on the oncology side of the business. She maintains an Outperform rating on Dynavax with a $40 per share fair value estimate.
01/16/18
LEHM
01/16/18
UPGRADE
LEHM
Overweight
GlaxoSmithKline upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Emmanuel Papadakis upgraded GlaxoSmithKline to Overweight from Equal Weight and raised his price target for the shares to GBP 16.50 from GBP 14.50. The analyst believes concerns are now reflected in the valuation and consensus expectations while HIV and shingles offer "sustainable drivers of mid-term growth."
01/16/18
LEHM
01/16/18
UPGRADE
LEHM
Overweight
GlaxoSmithKline upgraded to Overweight from Equal Weight at Barclays
HBAN Huntington Bancshares
$15.53

0.1 (0.65%)

01/24/18
01/24/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI with analyst Duane Pfennigwerth citing the company's investor update. 2. Huntington Bancshares (HBAN) was downgraded to Neutral from Buy at Hilliard Lyons and to Neutral from Outperform at Macquarie. 3. Range Resources (RRC) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Evan Calio saying he expects oil markets to tighten and gas to remain weak in 2018. 4. CEVA downgraded to Perform from Outperform at Oppenheimer with analyst Andrew Uerkwitz downgraded Ceva (CEVA) to Perform from Outperform saying the valuation looks "full" at current levels. 5. Aaron's (AAN) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation rather than fundamentals, forecasting the company's core business to improve sequentially and also see benefits from the U.S. tax changes. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/24/18
HDLY
01/24/18
DOWNGRADE
Target $17
HDLY
Neutral
Huntington Bancshares downgraded to Neutral from Buy at Hilliard Lyons
Hilliard Lyons analyst Andrew Stapp downgraded Huntington Bancshares to Neutral from Buy citing valuation. He raised his price target on the stock to $17.00 from $15.50.
11/15/17
MSCO
11/15/17
NO CHANGE
MSCO
Morgan Stanley says higher SIFI threshold could benefit Comerica, CIT, Zions
After Senate Banking Committee Chairman Mike Crapo proposed a bill in the Senate that would effectively remove the SIFI threshold for banks under $250B, Morgan Stanley analyst Ken Zerbe estimated that banks with $50B-$100B in assets could see a 12% increase in 2020 EPS and a 15% bump in 2021. He sees the largest potential increase at Comerica (CMA), followed by CIT Group (CIT) and Zions Bancorp (ZION). Zerbe projects the least EPS benefit for SunTrust (STI), Regions Financial (RF), Ally Financial (ALLY) and Discover (DFS), he tells investors. Other banks he lists in his note as potentially impacted by SIFI and CCAR changes include Synchrony (SYF), M&T Bank (MTB), KeyCorp (KEY), Fifth Third (FITB), BB&T (BBT), Citizens Financial (CFG) and Huntington Bancshares (HBAN).
01/24/18
MACQ
01/24/18
DOWNGRADE
MACQ
Neutral
Huntington Bancshares downgraded to Neutral from Outperform at Macquarie
Macquarie analyst David Konrad downgraded Huntington Bancshares to Neutral citing valuation and maintained a $16.50 price target.
MTCH Match Group
$33.26

-0.57 (-1.68%)

02/05/18
PIPR
02/05/18
NO CHANGE
Target $40
PIPR
Overweight
Match Group price target raised to $40 from $33 at Piper Jaffray
Piper Jaffray analyst Sam Kemp raised his price target for Match Group to $40 saying Tinder appears to be positioned to show Q4 upside. Further, January was Tinder's strongest month yet, which should prompt upwards revisions to 2018 revenue guidance, Kemp tells investors in a research note, citing Tinder's App Store grossing rank. The analyst reiterates an Overweight rating on Match Group.
12/19/17
GUGG
12/19/17
UPGRADE
GUGG
Buy
Match Group upgraded to Buy from Neutral at Guggenheim
02/02/18
JPMS
02/02/18
INITIATION
Target $175
JPMS
Overweight
IAC resumed with an Overweight at JPMorgan
JPMorgan analyst Doug Anmuth resumed coverage of IAC (IAC) with an Overweight rating and $175 price target. The current share price implies the company's non-Match Group (MTCH) and Angi Homeservices (ANGI) assets are valued at negative $1.4B enterprise value, Anmuth tells investors in a research note. He believes IAC represents one of the most compelling values in his coverage universe. The analyst also raised his price target for Match Group to $39 from $34 and reiterates an Overweight rating on the name.
01/08/18
WELS
01/08/18
NO CHANGE
Target $38
WELS
Outperform
Match Group price target raised to $38 from $33 at Wells Fargo
Wells Fargo analyst Peter Stabler raised his price target for Match Group to $38 from $33 as he believes 2018 will benefit from many of the same underlying trends as in 2017, including the widening use of artificial intelligence, the increasing reliance on mobile, and the growing importance of Cloud. The analyst reiterates an Outperform rating on the shares.
ETSY Etsy
$18.71

0.27 (1.46%)

01/12/18
01/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Hold from Buy at Stifel with analyst Scott Devitt arguing there is currently "too much uncertainty" relating to the economic impact of the company's pending News Feed changes communicated in a post last night by CEO Mark Zuckerberg. 2. Snap (SNAP) downgraded to Underperform from Market Perform at Raymond James with analyst Aaron Kessler saying Snap is largely a Chat/Message app and not a camera company as it refers to itself. 3. Etsy (ETSY) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Brian Nowak citing valuation as being too expensive compared to its peers and the stock's historical average. 4. Comcast (CMCSA) downgraded to Buy from Action List Buy at TD Securities with analyst Vince Valentin citing recent shares strength and to make room of new Action List addition Shaw Communications (SJR), where he now sees better upside potential. 5. Electronic Arts (EA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Brian Nowak citing disappointing "Star Wars: Battlefront 2" third party data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/12/18
MSCO
01/12/18
DOWNGRADE
Target $17
MSCO
Underweight
Etsy downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Brian Nowak downgraded Etsy to Underweight from Equal Weight, primarily citing valuation as being too expensive compared to its peers and the stock's historical average. Without evidence that the company's new management can drive faster than expected revenue growth, he believes investors may not continue to be willing to buy the stock at its current multiple, Nowak tells investors. However, given estimated cost savings from cloud migration and a lower expected tax rate, Nowak raised his price target on Etsy shares to $17 from $13.50.
12/20/17
KEYB
12/20/17
INITIATION
Target $26
KEYB
Overweight
Etsy initiated with an Overweight at KeyBanc
KeyBanc analyst Jason Gere started Etsy with an Overweight rating and $26 price target. The analyst says underlying double-digit secular growth, greater than 15% adjusted EBITDA margins and "visible self-help initiatives" make the company "unique" within e-commerce.
11/07/17
IFSG
11/07/17
NO CHANGE
IFSG
Etsy price target raised to $22 from $18 at IFS Securities
IFS Securities analyst Ronald Bookbinder increased his price target on Etsy to $22 from $18 and raised his FY17 and FY18 earnings per share estimates following Etsy's strong third quarter earnings results. Bookbinder believes profitability should continue to accelerate, and strong revenue growth will continue as Etsy works to drive gross merchandise sales. The analyst maintains an Outperform rating on Etsy shares.

TODAY'S FREE FLY STORIES

AAPL

Apple

$172.43

-0.56 (-0.32%)

16:18
02/19/18
02/19
16:18
02/19/18
16:18
Periodicals
Apple iPhone losing out to Chinese devices in Asia, WSJ reports »

Apple's iPhone X…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BLK

BlackRock

$541.10

0.45 (0.08%)

16:13
02/19/18
02/19
16:13
02/19/18
16:13
Periodicals
BlackRock upgrades outlook for stocks on earnings momentum, Reuters says »

BlackRock upgraded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 23

    Apr

FB

Facebook

$177.36

-2.6 (-1.44%)

16:06
02/19/18
02/19
16:06
02/19/18
16:06
Periodicals
Facebook increasing security team size following Russia indictment, Axios says »

Facebook reiterated it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

SNHY

Sun Hydraulics

$55.48

-0.74 (-1.32%)

16:02
02/19/18
02/19
16:02
02/19/18
16:02
Hot Stocks
Sun Hydraulics announces acquisition of Faster Group »

Sun Hydraulics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CCL

Carnival

$69.50

-0.1 (-0.14%)

15:59
02/19/18
02/19
15:59
02/19/18
15:59
Hot Stocks
Carnival Fascination resumes year-round service from San Juan »

Carnival Fascination…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

LUV

Southwest

$58.27

0.09 (0.15%)

15:58
02/19/18
02/19
15:58
02/19/18
15:58
Hot Stocks
Southwest Cargo team to begin shipping internationally in spring 2018 »

Southwest Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.16

-0.03 (-0.03%)

15:55
02/19/18
02/19
15:55
02/19/18
15:55
Hot Stocks
PPG appoints senior business director, mobility »

PPG announced that Ranju…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

15:51
02/19/18
02/19
15:51
02/19/18
15:51
Hot Stocks
Cubic announces semiannual dividend »

Cubic announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Jun

CREE

Cree

$36.71

0.21 (0.58%)

15:48
02/19/18
02/19
15:48
02/19/18
15:48
Hot Stocks
Cree names Thomas Wessel as senior vice president of Global Sales and Marketing »

Cree announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

DB

Deutsche Bank

$16.08

-0.03 (-0.19%)

13:59
02/19/18
02/19
13:59
02/19/18
13:59
Upgrade
Deutsche Bank rating change at BofA/Merrill »

Deutsche Bank upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

MNLO

Menlo Therapeutics

$34.88

-0.44 (-1.25%)

13:59
02/19/18
02/19
13:59
02/19/18
13:59
Initiation
Menlo Therapeutics initiated at Guggenheim »

Menlo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHPG

Shire

$134.06

-1.24 (-0.92%)

13:58
02/19/18
02/19
13:58
02/19/18
13:58
Downgrade
Shire rating change at JPMorgan »

Shire downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

  • 25

    Mar

CVR

Chicago Rivet & Machine

$31.62

-0.0725 (-0.23%)

13:48
02/19/18
02/19
13:48
02/19/18
13:48
Hot Stocks
Chicago Rivet & Machine announces increase in quarterly cash dividend »

On February 19, 2018 the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$26.28

-0.09 (-0.34%)

13:46
02/19/18
02/19
13:46
02/19/18
13:46
Hot Stocks
Noble announces execution of gas sales agreements for export of gas to Egypt »

Noble Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

TOT

Total

$57.13

0.29 (0.51%)

13:43
02/19/18
02/19
13:43
02/19/18
13:43
Hot Stocks
Total signs definitive agreements with Borealis, NOVA Chemicals to form JV »

Total, Borealis and NOVA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYY

Sysco

$60.00

0.63 (1.06%)

13:39
02/19/18
02/19
13:39
02/19/18
13:39
Hot Stocks
Sysco acquires Doerle Food Services »

Sysco announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 30

    May

SBGI

Sinclair Broadcast

$36.30

-0.95 (-2.55%)

, CMCSA

Comcast

$39.79

-0.29 (-0.72%)

13:36
02/19/18
02/19
13:36
02/19/18
13:36
Hot Stocks
Sinclair announces renewals of NBC affiliation agreements »

Sinclair Broadcast (SBGI)…

SBGI

Sinclair Broadcast

$36.30

-0.95 (-2.55%)

CMCSA

Comcast

$39.79

-0.29 (-0.72%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 05

    Mar

III

Information Services

$4.24

-0.02 (-0.47%)

13:33
02/19/18
02/19
13:33
02/19/18
13:33
Hot Stocks
Information Services releases first client-facing mobile app »

Information Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 29

    Mar

  • 12

    Apr

CAT

Caterpillar

$156.29

-3.69 (-2.31%)

13:24
02/19/18
02/19
13:24
02/19/18
13:24
Hot Stocks
Tony Fassino appointed vice president of Caterpillar's BCP division »

Caterpillar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$102.49

-0.16 (-0.16%)

13:22
02/19/18
02/19
13:22
02/19/18
13:22
Hot Stocks
Celanese CFO Chris Jensen steps down, Scott Richardson to succeed »

Celanese announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

WOR

Worthington

$46.70

0.57 (1.24%)

, JPM

JPMorgan

$114.68

-0.83 (-0.72%)

13:18
02/19/18
02/19
13:18
02/19/18
13:18
Hot Stocks
Worthington extends existing $500M revolving credit facility »

Worthington Industries…

WOR

Worthington

$46.70

0.57 (1.24%)

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

PNC

PNC Financial

$159.08

-0.78 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

  • 27

    Feb

  • 07

    Mar

  • 13

    Mar

  • 13

    Apr

  • 13

    Apr

  • 30

    May

  • 13

    Jul

  • 14

    Jul

  • 12

    Oct

  • 12

    Oct

VJET

voxeljet

13:15
02/19/18
02/19
13:15
02/19/18
13:15
Hot Stocks
TEI, voxeljet sign volume contract for 3D printed sand »

voxeljet AG announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$78.97

0.95 (1.22%)

13:11
02/19/18
02/19
13:11
02/19/18
13:11
Hot Stocks
Treatment with Eli Lilly Taltz resulted in improvement in genital psoriasis »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 04

    Apr

  • 23

    Apr

  • 07

    Jun

ALV

Autoliv

$145.81

-0.64 (-0.44%)

13:07
02/19/18
02/19
13:07
02/19/18
13:07
Hot Stocks
Autoliv new electronics spinoff company to be named Veoneer »

Autoliv announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$39.91

0.19 (0.48%)

13:04
02/19/18
02/19
13:04
02/19/18
13:04
Hot Stocks
Tuberculosis vaccine trial results offer potential for new BCG strategies »

Aeras announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 25

    Mar

  • 02

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.